Orbis Diagnostics
PrivateLast Round
VC Round
May 30, 2025
Total Funding Raised
$3.67M
Company Overview
Orbis Diagnostics operates in Healthcare & Life Sciences and is based in Auckland. Its latest recorded funding round was a Grant round in August 2024.
Orbis Diagnostics is a healthtech company that is developing a point-of-care diagnostics platform capable of delivering clinically-accurate blood test results from a single fingerstick of blood.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbis Diagnostics Comparables
Compare Orbis Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Truvian | 87% | |
| biosurfit | 82% | |
| Soulbrain Holdings Co. Ltd | 77% |
For institutional investors. Book with your work email.
Orbis Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 30, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Seed | May 20, 2022 | ||||
| Series A | Nov 16, 2021 | ||||
| VC Round | Oct 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orbis Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Grant |
| Even Capital | Seed, Series A |
| Booster Innovation Fund | Seed |
| Pacific Channel | VC Round, Series A |
| Clare Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Mar 19, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Orbis Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orbis Diagnostics's valuation, stock price, and market status.
Is Orbis Diagnostics a public or private company?
Orbis Diagnostics is a private company.
What is the current stock price of Orbis Diagnostics?
Orbis Diagnostics is a private company, so its shares have no public market price. Caplight tracks Orbis Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orbis Diagnostics worth (valuation)?
Valuation information for Orbis Diagnostics is not publicly available.
Can I buy Orbis Diagnostics stock?
Orbis Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orbis Diagnostics's last funding round?
Orbis Diagnostics's most recent funding round was VC Round on May 30, 2025.
Who are the main investors in Orbis Diagnostics?
Key investors in Orbis Diagnostics include Pacific Channel.
Will Orbis Diagnostics IPO soon?
No public IPO plans have been announced for Orbis Diagnostics.
How can I track Orbis Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Orbis Diagnostics's shares on secondary markets.